Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$26.24 - $39.63 $71.4 Million - $108 Million
2,719,573 Added 219.27%
3,959,870 $156 Million
Q1 2023

May 15, 2023

SELL
$18.67 - $24.56 $17.4 Million - $22.9 Million
-931,236 Reduced 42.88%
1,240,297 $30.2 Million
Q4 2022

Feb 14, 2023

BUY
$17.24 - $23.95 $14.6 Million - $20.3 Million
846,603 Added 63.9%
2,171,533 $46.5 Million
Q3 2022

Nov 14, 2022

SELL
$9.4 - $18.59 $2.67 Million - $5.29 Million
-284,565 Reduced 17.68%
1,324,930 $23.8 Million
Q2 2022

Aug 15, 2022

BUY
$9.12 - $18.9 $3.16 Million - $6.55 Million
346,536 Added 27.44%
1,609,495 $15.5 Million
Q1 2022

May 16, 2022

SELL
$12.15 - $16.83 $2.54 Million - $3.52 Million
-208,989 Reduced 14.2%
1,262,959 $21.3 Million
Q4 2021

Feb 14, 2022

BUY
$13.83 - $18.78 $10.1 Million - $13.7 Million
731,394 Added 98.76%
1,471,948 $24.6 Million
Q3 2021

Nov 15, 2021

SELL
$7.07 - $17.5 $2.91 Million - $7.2 Million
-411,396 Reduced 35.71%
740,554 $12 Million
Q2 2021

Aug 16, 2021

BUY
$5.69 - $7.17 $1.85 Million - $2.34 Million
325,936 Added 39.46%
1,151,950 $7.27 Million
Q1 2021

May 17, 2021

BUY
$5.08 - $6.89 $108,645 - $147,356
21,387 Added 2.66%
826,014 $5.11 Million
Q4 2020

Feb 16, 2021

SELL
$5.65 - $7.66 $749,834 - $1.02 Million
-132,714 Reduced 14.16%
804,627 $5.56 Million
Q3 2020

Nov 16, 2020

BUY
$4.01 - $6.29 $57,651 - $90,431
14,377 Added 1.56%
937,341 $5.29 Million
Q2 2020

Aug 14, 2020

SELL
$3.06 - $6.6 $1.3 Million - $2.81 Million
-425,536 Reduced 31.56%
922,964 $4.71 Million
Q1 2020

May 14, 2020

BUY
$2.83 - $8.44 $1.34 Million - $4.01 Million
474,633 Added 54.31%
1,348,500 $4.64 Million
Q4 2019

Feb 14, 2020

BUY
$0.93 - $8.58 $812,696 - $7.5 Million
873,867 New
873,867 $7.5 Million
Q3 2019

Nov 14, 2019

SELL
$1.09 - $1.29 $30,745 - $36,387
-28,207 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$1.21 - $1.48 $33,193 - $40,600
27,433 Added 3544.32%
28,207 $37,000
Q2 2019

Aug 14, 2019

BUY
$1.21 - $1.48 $936 - $1,145
774 New
774 $3.2 Million

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.